+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sevoflurane for Inhalation Market - Global Forecast 2025-2030- Product Image
Sevoflurane for Inhalation Market - Global Forecast 2025-2030- Product Image
Sale

Sevoflurane for Inhalation Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6126390
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sevoflurane stands as a crucial agent in modern inhalation anesthesia, offering healthcare providers the flexibility and speed needed for efficient surgical care across multiple patient and procedure types. As evolving care models emphasize quality, operational efficiency, and patient safety, the sevoflurane market continues to adapt through ongoing technological and regulatory changes that influence procurement, adoption, and delivery methods.

Market Snapshot: Sevoflurane Market Size and Trajectory

The sevoflurane market has experienced steady expansion, propelled by the agent’s rapid onset, favorable recovery profile, and adaptability across a spectrum of clinical environments. Demand is consistently supported by healthcare institutions seeking scalable anesthesia solutions to manage increasing surgical volumes and evolving acuity demands. Ongoing advancements in anesthesia technology and streamlined delivery further reinforce the market’s upward trajectory, positioning sevoflurane as a preferred option for both established hospitals and emerging outpatient centers.

Scope & Segmentation

This report provides actionable insights into the following areas:

  • End Users: Ambulatory surgical centers, clinics, private hospitals, public hospitals, teaching hospitals, research institutions.
  • Product Types: Branded formulations emphasizing advanced safety features or dedicated service models, and generic versions suited for price-focused and high-volume buyers.
  • Applications: Induction protocols that benefit from rapid onset, and maintenance usage prioritizing hemodynamic stability during longer procedures.
  • Distribution Channels: Direct sales fostering close provider relationships, national and regional distributors offering extensive or tailored reach, and e-commerce platforms for on-demand procurement.
  • Key Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), EMEA (including United Kingdom, Germany, France, UAE, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and additional fast-growing healthcare markets).
  • Leading Companies: Baxter International Inc., Piramal Enterprises Limited, Halocarbon Products Corporation, Viatris Inc., B. Braun Melsungen AG, and select major Chinese pharmaceutical firms.
  • Technological Developments: Advanced vaporizers, digital monitoring platforms, closed-circuit systems, gas scavenging technologies, and environmental stewardship features.

Primary Keyword: Sevoflurane Market

Key Takeaways

  • Sevoflurane’s low blood solubility enables anesthesiologists to optimize patient flow, from induction through recovery, critical for busy surgical and outpatient environments.
  • Regulatory support and alignment, reinforced by thorough approvals, foster institutional confidence and facilitate broader adoption despite varying national standards.
  • Investment in precision vaporizers and automated monitoring platforms increases dosing consistency while supporting patient safety and operational efficiency.
  • Sustainability priorities are shaping procurement decisions, with institutions increasingly adopting closed-system technologies to reduce occupational and environmental exposure.
  • Strategic supply diversification and nearshoring initiatives have become vital, especially in response to tariff shifts and trade disruptions impacting raw materials and finished products.
  • Competitive dynamics are marked by mergers, partnerships with research institutes, and an active innovation pipeline, expanding clinical applications and delivery model options.

Tariff Impact on Supply Chains and Clinical Adoption

The introduction of new tariffs on pharmaceutical imports in the U.S. has compelled stakeholders across the supply chain—suppliers, manufacturers, and healthcare providers—to reexamine sourcing and distribution. Hospitals and purchasing groups increasingly pursue domestic or nearshore alternatives and diversify supplier portfolios to mitigate volatility. This structural shift spurs greater emphasis on multi-year agreements and risk-sharing partnerships, enhancing both resilience and preparedness. Efforts to engage policymakers for tariff classification review and possible exemptions further reflect the sector’s collaborative approach to maintaining sevoflurane availability.

Methodology & Data Sources

Insights provided are underpinned by a hybrid methodology combining interviews with clinicians, procurement experts, and supply chain leaders, as well as structured surveys on formulation and technology preferences. Secondary research included rigorous analysis of clinical literature, regulatory filings, competitive white papers, and conference proceedings to triangulate findings and ensure analytical accuracy.

Why This Report Matters

  • Enables hospital executives and supply chain leaders to make informed, evidence-based decisions in anesthesia procurement, technology adoption, and supplier engagement.
  • Highlights evolving market conditions, competitive strategies, and regulatory shifts impacting operational and clinical outcomes.
  • Offers segmentation and channel insights tailored to optimize resource allocation within diverse procedural and care delivery contexts.

Conclusion

Adapting to evolving clinical priorities and market complexities, stakeholders in the sevoflurane market can leverage this report to drive innovation, strengthen operational resilience, and secure sustainable growth. Ongoing advances and strategic collaborations continue to define a dynamic competitive landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing regulatory approvals for sevoflurane derivatives in emerging markets driving market expansion
5.2. Growing demand for low-solubility anesthetics boosting research investments into new sevoflurane formulations
5.3. Strategic partnerships between pharmaceutical companies and hospitals to enhance sevoflurane supply chain resilience
5.4. Integration of advanced vaporizer technologies improving precision administration of sevoflurane in operating rooms
5.5. R&D focus on minimizing environmental impact of sevoflurane through green chemistry and waste reduction initiatives
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sevoflurane for Inhalation Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics
8.4. Hospitals
8.4.1. Private Hospitals
8.4.2. Public Hospitals
8.4.3. Teaching Hospitals
8.5. Research Institutions
9. Sevoflurane for Inhalation Market, by Product
9.1. Introduction
9.2. Branded
9.3. Generic
10. Sevoflurane for Inhalation Market, by Application
10.1. Introduction
10.2. Induction
10.3. Maintenance
11. Sevoflurane for Inhalation Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.3.1. National Distributors
11.3.2. Regional Distributors
11.4. E-Commerce
12. Americas Sevoflurane for Inhalation Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Sevoflurane for Inhalation Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Sevoflurane for Inhalation Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Baxter International Inc.
15.3.2. Piramal Enterprises Limited
15.3.3. Halocarbon Products Corporation
15.3.4. Viatris Inc.
15.3.5. B. Braun Melsungen AG
15.3.6. Anhui Kanglong Pharmaceutical Co., Ltd.
15.3.7. Jiangsu Nhwa Pharmaceutical Co., Ltd.
15.3.8. Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
15.3.9. Hainan Eastern Bio-Pharmaceutical Co., Ltd.
15.3.10. China National Pharmaceutical Group Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SEVOFLURANE FOR INHALATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. SEVOFLURANE FOR INHALATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. SEVOFLURANE FOR INHALATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. SEVOFLURANE FOR INHALATION MARKET: RESEARCHAI
FIGURE 24. SEVOFLURANE FOR INHALATION MARKET: RESEARCHSTATISTICS
FIGURE 25. SEVOFLURANE FOR INHALATION MARKET: RESEARCHCONTACTS
FIGURE 26. SEVOFLURANE FOR INHALATION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SEVOFLURANE FOR INHALATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY INDUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY INDUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SEVOFLURANE FOR INHALATION MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 81. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 84. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 85. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 86. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 87. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 92. CANADA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 93. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 96. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 97. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 98. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 99. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 104. MEXICO SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 155. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 166. GERMANY SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 167. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 172. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 173. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 178. FRANCE SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 191. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 196. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 197. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 202. ITALY SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 203. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 206. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 207. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 208. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 209. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 214. SPAIN SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 251. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 254. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 255. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 256. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 257. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 262. DENMARK SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 275. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 278. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 279. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 280. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 281. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 286. QATAR SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 287. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 290. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 291. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 292. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 293. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 298. FINLAND SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA SEVOFLURANE FOR INHALATION MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 323. EGYPT SE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sevoflurane for Inhalation market report include:
  • Baxter International Inc.
  • Piramal Enterprises Limited
  • Halocarbon Products Corporation
  • Viatris Inc.
  • B. Braun Melsungen AG
  • Anhui Kanglong Pharmaceutical Co., Ltd.
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
  • Hainan Eastern Bio-Pharmaceutical Co., Ltd.
  • China National Pharmaceutical Group Co., Ltd.

Related Topics

Related Reports

Inhalation Sevoflurane Anaesthetic Agent Market - Global Forecast 2025-2030 - Product Image

Inhalation Sevoflurane Anaesthetic Agent Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Inhalation Sevoflurane Anesthesia Drugs Market - Global Forecast 2025-2030 - Product Image

Inhalation Sevoflurane Anesthesia Drugs Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Inhalation Anesthesia Market Size, Share & Trends Analysis Report by Drug (Sevoflurane, Desflurane), Application (Induction, Maintenance), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Inhalation Anesthesia Market Size, Share & Trends Analysis Report by Drug (Sevoflurane, Desflurane), Application (Induction, Maintenance), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Inhalation Anesthesia: Market Share, and Growth Analysis by Product (Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide), Application, End User - Product Image

Inhalation Anesthesia: Market Share, and Growth Analysis by Product (Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide), Application, End User

  • Report
  • 150 Pages
  • Global
From
Inhalation Anesthetics - Global Strategic Business Report - Product Image

Inhalation Anesthetics - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.